- Home
- SKX vs QGEN Comparison
SKX vs QGEN Comparison
Compare SKX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- QGEN
- Stock Information
- Founded
- SKX 1992
- QGEN 1986
- Country
- SKX United States
- QGEN Netherlands
- Employees
- SKX N/A
- QGEN N/A
- Industry
- SKX Shoe Manufacturing
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKX Consumer Discretionary
- QGEN Health Care
- Exchange
- SKX Nasdaq
- QGEN Nasdaq
- Market Cap
- SKX 8.7B
- QGEN 9.9B
- IPO Year
- SKX 1999
- QGEN 1996
- Fundamental
- Price
- SKX $55.96
- QGEN $38.91
- Analyst Decision
- SKX Strong Buy
- QGEN Buy
- Analyst Count
- SKX 12
- QGEN 8
- Target Price
- SKX $81.45
- QGEN $49.79
- AVG Volume (30 Days)
- SKX 2.6M
- QGEN 1.2M
- Earning Date
- SKX 04-24-2025
- QGEN 04-28-2025
- Dividend Yield
- SKX N/A
- QGEN 3.38%
- EPS Growth
- SKX 19.20
- QGEN N/A
- EPS
- SKX 4.16
- QGEN 0.37
- Revenue
- SKX $8,969,351,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- SKX $10.00
- QGEN $5.15
- Revenue Next Year
- SKX $8.87
- QGEN $6.49
- P/E Ratio
- SKX $13.45
- QGEN $105.14
- Revenue Growth
- SKX 12.11
- QGEN 0.66
- 52 Week Low
- SKX $53.79
- QGEN $37.63
- 52 Week High
- SKX $78.85
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- SKX 32.50
- QGEN 41.25
- Support Level
- SKX $53.79
- QGEN $38.76
- Resistance Level
- SKX $57.46
- QGEN $39.86
- Average True Range (ATR)
- SKX 2.29
- QGEN 0.71
- MACD
- SKX -0.28
- QGEN 0.23
- Stochastic Oscillator
- SKX 20.81
- QGEN 51.20
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).